Header Logo

Connection

Douglas Corley to Barrett Esophagus

Back to Details
This is a "connection" page, showing publications Douglas Corley has written about Barrett Esophagus.
Douglas Corley
Connection Strength
15.377
Barrett Esophagus
  1. Will a Proton Pump Inhibitor and an Aspirin Keep the Doctor Away for Patients With Barrett's Esophagus? Gastroenterology. 2019 04; 156(5):1228-1231.
    View in: PubMed
    Score: 0.599
  2. The Troublesome Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma. Gastrointest Endosc Clin N Am. 2017 Jul; 27(3):353-364.
    View in: PubMed
    Score: 0.534
  3. Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort. Gut. 2018 03; 67(3):418-529.
    View in: PubMed
    Score: 0.516
  4. Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus. Am J Gastroenterol. 2016 11; 111(11):1528-1535.
    View in: PubMed
    Score: 0.504
  5. Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett's Esophagus. Dig Dis Sci. 2016 Jan; 61(1):70-9.
    View in: PubMed
    Score: 0.472
  6. Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease. Clin Gastroenterol Hepatol. 2015 Dec; 13(13):2256-64.e1-3.
    View in: PubMed
    Score: 0.451
  7. Does Human Papillomavirus Cause Esophageal Adenocarcinoma? Clin Gastroenterol Hepatol. 2015 Jul; 13(7):1369-70.
    View in: PubMed
    Score: 0.448
  8. A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma. Best Pract Res Clin Gastroenterol. 2015 Feb; 29(1):29-39.
    View in: PubMed
    Score: 0.446
  9. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of Barrett's esophagus. Dig Dis Sci. 2015 Feb; 60(2):436-43.
    View in: PubMed
    Score: 0.439
  10. Alcohol and the risk of Barrett's esophagus: a pooled analysis from the International BEACON Consortium. Am J Gastroenterol. 2014 Oct; 109(10):1586-94.
    View in: PubMed
    Score: 0.435
  11. Reply: To PMID 23673354. Gastroenterology. 2014 Feb; 146(2):588-9.
    View in: PubMed
    Score: 0.418
  12. Can You Stop Surveillance After Radiofrequency Ablation of Barrett's Esophagus? A Glass Half Full. Gastroenterology. 2013 Jul; 145(1):39-42.
    View in: PubMed
    Score: 0.402
  13. Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas. Gastroenterology. 2013 Aug; 145(2):312-9.e1.
    View in: PubMed
    Score: 0.401
  14. Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium. Gut. 2013 Dec; 62(12):1684-91.
    View in: PubMed
    Score: 0.393
  15. Barrett's esophagus: who should receive ablation and how can we get the best results? Gastroenterology. 2012 Sep; 143(3):524-526.
    View in: PubMed
    Score: 0.379
  16. Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Gastroenterology. 2012 Apr; 142(4):744-53.
    View in: PubMed
    Score: 0.365
  17. Understanding cancer incidence in Barrett's esophagus: light at the end of the tunnel. J Natl Cancer Inst. 2011 Jul 06; 103(13):994-5.
    View in: PubMed
    Score: 0.351
  18. Chemoprevention in Barrett's esophagus: are we there yet, are we there yet...? Clin Gastroenterol Hepatol. 2009 Dec; 7(12):1266-8.
    View in: PubMed
    Score: 0.311
  19. Diagnosing Barrett's esophagus: reliability of clinical and pathologic diagnoses. Gastrointest Endosc. 2009 May; 69(6):1004-10.
    View in: PubMed
    Score: 0.297
  20. Effects of dietary fiber, fats, and meat intakes on the risk of Barrett's esophagus. Nutr Cancer. 2009; 61(5):607-16.
    View in: PubMed
    Score: 0.296
  21. Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus. Gastroenterology. 2009 Mar; 136(3):806-15.
    View in: PubMed
    Score: 0.294
  22. Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. Gut. 2009 Feb; 58(2):182-8.
    View in: PubMed
    Score: 0.293
  23. Cigarette smoking and the risk of Barrett's esophagus. Cancer Causes Control. 2009 Apr; 20(3):303-11.
    View in: PubMed
    Score: 0.292
  24. Iron intake and body iron stores as risk factors for Barrett's esophagus: a community-based study. Am J Gastroenterol. 2008 Dec; 103(12):2997-3004.
    View in: PubMed
    Score: 0.291
  25. Dietary antioxidants, fruits, and vegetables and the risk of Barrett's esophagus. Am J Gastroenterol. 2008 Jul; 103(7):1614-23; quiz 1624.
    View in: PubMed
    Score: 0.286
  26. Hemochromatosis gene status as a risk factor for Barrett's esophagus. Dig Dis Sci. 2008 Dec; 53(12):3095-102.
    View in: PubMed
    Score: 0.283
  27. Cancer incidence in Barrett's esophagus: does it really matter, and who's counting anyway? Gastrointest Endosc. 2008 Mar; 67(3):399-401.
    View in: PubMed
    Score: 0.279
  28. Dietary patterns and the risk of Barrett's esophagus. Am J Epidemiol. 2008 Apr 01; 167(7):839-46.
    View in: PubMed
    Score: 0.277
  29. Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut. 2008 Jun; 57(6):727-33.
    View in: PubMed
    Score: 0.271
  30. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007 Jul; 133(1):34-41; quiz 311.
    View in: PubMed
    Score: 0.263
  31. Constrained Score Statistics Identify Genetic Variants Interacting with Multiple Risk Factors in Barrett's Esophagus. Am J Hum Genet. 2016 08 04; 99(2):352-65.
    View in: PubMed
    Score: 0.251
  32. Barrett's esophagus and medications that relax the lower esophageal sphincter. Am J Gastroenterol. 2006 May; 101(5):937-44.
    View in: PubMed
    Score: 0.246
  33. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology. 2002 Mar; 122(3):633-40.
    View in: PubMed
    Score: 0.184
  34. Validation of Tools for Predicting Incident Adenocarcinoma of the Esophagus or Esophagogastric Junction. Am J Gastroenterol. 2021 05 01; 116(5):949-957.
    View in: PubMed
    Score: 0.174
  35. Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma. Carcinogenesis. 2021 04 17; 42(3):369-377.
    View in: PubMed
    Score: 0.174
  36. Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterology. 2020 12; 159(6):2065-2076.e1.
    View in: PubMed
    Score: 0.166
  37. Association Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus. Clin Gastroenterol Hepatol. 2020 11; 18(12):2701-2709.e3.
    View in: PubMed
    Score: 0.157
  38. Diabetes in relation to Barrett's esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett's and Esophageal Adenocarcinoma Consortium. Cancer. 2019 12 01; 125(23):4210-4223.
    View in: PubMed
    Score: 0.155
  39. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants. Gastroenterology. 2018 04; 154(5):1273-1281.e3.
    View in: PubMed
    Score: 0.138
  40. Dietary sugar/starches intake and Barrett's esophagus: a pooled analysis. Eur J Epidemiol. 2017 11; 32(11):1007-1017.
    View in: PubMed
    Score: 0.135
  41. Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis. Lancet Oncol. 2016 Oct; 17(10):1363-1373.
    View in: PubMed
    Score: 0.125
  42. Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma. Gut. 2017 10; 66(10):1739-1747.
    View in: PubMed
    Score: 0.125
  43. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma. Cancer Med. 2016 09; 5(9):2657-65.
    View in: PubMed
    Score: 0.125
  44. Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis. Clin Gastroenterol Hepatol. 2016 10; 14(10):1412-1419.e3.
    View in: PubMed
    Score: 0.124
  45. Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma. Int J Cancer. 2016 Mar 01; 138(5):1146-52.
    View in: PubMed
    Score: 0.118
  46. Polymorphisms in Genes of Relevance for Oestrogen and Oxytocin Pathways and Risk of Barrett's Oesophagus and Oesophageal Adenocarcinoma: A Pooled Analysis from the BEACON Consortium. PLoS One. 2015; 10(9):e0138738.
    View in: PubMed
    Score: 0.118
  47. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus. Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11):1739-47.
    View in: PubMed
    Score: 0.118
  48. Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium. Gastroenterology. 2015 Nov; 149(6):1599-606.
    View in: PubMed
    Score: 0.117
  49. MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium. PLoS One. 2015; 10(6):e0128617.
    View in: PubMed
    Score: 0.116
  50. BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol. 2015 May; 110(5):662-82; quiz 683.
    View in: PubMed
    Score: 0.114
  51. Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus. Gastroenterology. 2015 Feb; 148(2):367-78.
    View in: PubMed
    Score: 0.111
  52. Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma. Carcinogenesis. 2014 Dec; 35(12):2740-7.
    View in: PubMed
    Score: 0.110
  53. Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study. J Natl Cancer Inst. 2014 Nov; 106(11).
    View in: PubMed
    Score: 0.110
  54. Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. J Natl Cancer Inst. 2013 Nov 20; 105(22):1711-8.
    View in: PubMed
    Score: 0.103
  55. A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet. 2013 Dec; 45(12):1487-93.
    View in: PubMed
    Score: 0.103
  56. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet. 2012 Oct; 44(10):1131-6.
    View in: PubMed
    Score: 0.096
  57. The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on imaging in Barrett's Esophagus. Gastrointest Endosc. 2012 Aug; 76(2):252-4.
    View in: PubMed
    Score: 0.095
  58. A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology. 2012 Oct; 143(4):917-26.e1.
    View in: PubMed
    Score: 0.095
  59. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology. 2012 Aug; 143(2):336-46.
    View in: PubMed
    Score: 0.093
  60. Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus. Nutr Res Rev. 2010 Dec; 23(2):230-46.
    View in: PubMed
    Score: 0.082
  61. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology. 2004 Jul; 127(1):310-30.
    View in: PubMed
    Score: 0.054
  62. Pleiotropic analysis of cancer risk loci on esophageal adenocarcinoma risk. Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11):1801-3.
    View in: PubMed
    Score: 0.029
  63. Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomization. Clin Gastroenterol Hepatol. 2014 Oct; 12(10):1667-76.e1.
    View in: PubMed
    Score: 0.026

© 2024 Kaiser Permanente